Journal article

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

Eric Faulkner, Anke-Peggy Holtorf, Surrey Walton, Christine Y Liu, Hwee Lin, Eman Biltaj, Diana Brixner, Charles Barr, Jennifer Oberg, Gurmit Shandhu, Uwe Siebert, Susan R Snyder, Simran Tiwana, John Watkins, Maarten J Ijzerman, Katherine Payne

VALUE IN HEALTH | ELSEVIER SCIENCE INC | Published : 2020

Abstract

Precision medicine is a dynamic area embracing a diverse and increasing type of approaches that allow the targeting of new medicines, screening programs or preventive healthcare strategies, which include the use of biologic markers or complex tests driven by algorithms also potentially taking account of patient preferences. The International Society for Pharmacoeconomics and Outcome Research expanded its current work around precision medicine to (1) describe the evolving paradigm of precision medicine with examples of current and evolving applications, (2) describe key stakeholders perspectives on the value of precision medicine in their respective domains, and (3) define the core factors th..

View full abstract

Grants

Funding Acknowledgements

We extend special thanks to Theresa Tesoro and Clarissa Cooblall at ISPOR, the professional society for health economics and outcomes research. We especially thank the individuals who submitted written comments on drafts of our manuscript; Gouri Shankar Bhattacharyya, Cornelis Boersma, Benjamin Craig, Godofreda Dalmacion, Beth Devine, Tatiana Dilla, Clare Foy, Lou Garrison, M. Ragan Hart, John Hornberger, Reuben Howden, J Ross Maclean, Ethna McFerran, Kathryn Phillips, Molly Purser, Brock Schroeder, Scott Spencer, Vincenzo Straccia, Renske ten Ham, Kevin Wilson, and Lin Zhang. All authors volunteered their time for discussion, research, and writing of this report. This research was supported in part by ISPOR, which contributed two staff liaisons for this project. We extend special thanks to Theresa Tesoro and Clarissa Cooblall at ISPOR, the professional society for health economics and outcomes research. We especially thank the individuals who submitted written comments on drafts of our manuscript; Gouri Shankar Bhattacharyya, Cornelis Boersma, Benjamin Craig, Godofreda Dalmacion, Beth Devine, Tatiana Dilla, Clare Foy, Lou Garrison, M. Ragan Hart, John Hornberger, Reuben Howden, J Ross Maclean, Ethna McFerran, Kathryn Phillips, Molly Purser, Brock Schroeder, Scott Spencer, Vincenzo Straccia, Renske ten Ham, Kevin Wilson, and Lin Zhang. All authors volunteered their time for discussion, research, and writing of this report. This research was supported in part by ISPOR, which contributed two staff liaisons for this project.